↓ Skip to main content

Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation

Overview of attention for article published in Journal of Translational Medicine, March 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
107 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation
Published in
Journal of Translational Medicine, March 2014
DOI 10.1186/1479-5876-12-58
Pubmed ID
Authors

Nadia Zakaria, Tine Possemiers, Sorcha Ní Dhubhghaill, Inge Leysen, Jos Rozema, Carina Koppen, Jean-Pierre Timmermans, Zwi Berneman, Marie-Jose Tassignon

Abstract

To determine if a standardized, non-xenogenic, reduced manipulation cultivation and surgical transplantation of limbal stem cell grafts is a safe and effective treatment option for patients with total and partial limbal stem cell deficiency.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 107 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 15%
Student > Ph. D. Student 14 13%
Other 11 10%
Student > Master 11 10%
Student > Bachelor 10 9%
Other 18 17%
Unknown 27 25%
Readers by discipline Count As %
Medicine and Dentistry 35 33%
Agricultural and Biological Sciences 13 12%
Biochemistry, Genetics and Molecular Biology 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Engineering 3 3%
Other 9 8%
Unknown 34 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2014.
All research outputs
#20,655,488
of 25,371,288 outputs
Outputs from Journal of Translational Medicine
#3,419
of 4,634 outputs
Outputs of similar age
#174,351
of 236,221 outputs
Outputs of similar age from Journal of Translational Medicine
#48
of 83 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,634 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,221 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.